| Oct 31 |
Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET
|
| Oct 23 |
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
|
| Oct 21 |
Lantern Pharma to Host & Participate in Two Public Webinars During October
|
| Oct 15 |
Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
|
| Oct 9 |
Lantern Pharma Inc (LTRN) Q2 2024 Earnings Call Highlights: Promising Clinical Trials and ...
|
| Sep 23 |
Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children’s Cancers
|
| Aug 31 |
Lantern Pharma Inc. (LTRN): A Penny Stock That Will Make You a Millionaire
|
| Aug 12 |
LTRN: Second Quarter Results
|
| Aug 10 |
Lantern Pharma Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 10 |
Lantern Pharma Inc. (LTRN) Q2 2024 Earnings Call Transcript
|
